Invus Public Equities, L.P.
CIK 1340097 · last filed 2024-12-12
Invus Public Equities, L.P. is a corporate insider who has filed 9 SEC Form 4 insider transactions across 3 companies since 2018. The most recent filing shows the insider sold $333.2M of SRRK on Dec 12, 2024. Across all open-market trades the lifetime net is −$307.9M, making them a net seller over the disclosed history. Current disclosed insider exposure totals $548.4M across reported positions. The firm reports its address in New York, NY. 52 SEC filings were submitted jointly with Invus Public Equities Advisors, LLC.
"Disclosed insider exposure" sums this person's most-recently-reported share counts across each company they're an insider in, multiplied by the current underlying price. It is not net worth — it misses retail holdings, private investments, real estate, index funds, and any company where the person isn't an SEC-reporting insider. For informational purposes only.
$548.37M
3
9
-$307.87M
Filer Profile
750 LEXINGTON AVENUE, 30TH FLOOR
NEW YORK, NY 10022
Holdings By Company
| Symbol | Role | Shares | Price | Disclosed Exposure | Lifetime OM Net | Filings | Latest Filed |
|---|---|---|---|---|---|---|---|
| SRRK | 10%+ Owner | 9,700,005 | $55.41 | $537.48M | -$160.57M | 5 | 2024-12-12 |
| CRESCENT BIOPHARMA, INC. (GLYC) Delisted | 10%+ Owner | 66,957 | $15.70 | $1.05M | -$1.49M | 3 | 2024-08-07 |
| SEER | 10%+ Owner | 5,588,366 | $1.95 | $10.90M | -$145.81M | 1 | 2021-02-03 |
Recent Filings
9 filings| Filed | Symbol | Action | Net Shares | Net $ | Link |
|---|---|---|---|---|---|
| 2024-12-12 | SRRK | Sell (S) | −8,000,000 | -$333.20M | EDGAR |
| 2024-08-07 | CRESCENT BIOPHARMA, INC. (GLYC) Delisted | Sell (S) | −1,101,275 | -$205.9K | EDGAR |
| 2024-07-30 | CRESCENT BIOPHARMA, INC. (GLYC) Delisted | Sell (S) | −6,895,595 | -$1.58M | EDGAR |
| 2023-10-16 | SRRK | Buy (P) | +17,599,448 | $120.69M | EDGAR |
| 2023-05-02 | SRRK | Buy (P) | +252,456 | $1.62M | EDGAR |
| 2023-02-13 | CRESCENT BIOPHARMA, INC. (GLYC) Delisted | Buy (P) | +91,608 | $297.0K | EDGAR |
| 2023-01-11 | SRRK | Sell (S) | −8,752 | -$83.0K | EDGAR |
| 2021-02-03 | SEER | Sell (S) | −2,272,905 | -$145.81M | EDGAR |
| 2018-05-31 | SRRK | Mixed | +19,168,320 | $50.40M | EDGAR |
Notice (144 / 144/A): Form 144 is a notice of intent to sell restricted/control stock under Rule 144, filed before the sale; 144/A is an amendment. Many notices are pre-scheduled under Rule 10b5-1 plans. A Form 4 with code S typically follows within a few days when the planned sale executes; missing follow-up Form 4s suggest the notice was cancelled or modified.